ARS Pharmaceuticals, Inc. SPRY
NASDAQ · United States · Health Technology
$4.07-0.05 (-1.21%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.63 | -0.48 | -31.9% | $33.66M | +7.5% | -6.6%$6.05→$5.65 |
| Q1 2026 | 2026-05-15 | -0.61 | -0.53 | -15.1% | — | — | -8.1%$7.94→$7.30 |
| Q4 2025 | 2026-03-09 | -0.42 | -0.48 | +12.5% | — | — | -2.2%$9.06→$8.86 |
| Q3 2025 | 2025-11-10 | -0.52 | -0.49 | -6.1% | — | — | -0.9%$8.85→$8.77 |
| Q2 2025 | 2025-08-13 | -0.46 | -0.51 | +9.8% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.35 | -0.36 | +2.8% | — | — | — |
| Q4 2024 | 2025-03-20 | 0.51 | -0.12 | +525.0% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.20 | -0.14 | -42.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.